| Jan 7, 2026 |
Jan 9, 2026 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Sell |
35.0
|
-4,652,309
|
-100.00%
|
✗
|
$1B |
| Jan 7, 2026 |
Jan 7, 2026 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2026 |
Jan 7, 2026 |
Spencer Ryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2026 |
Jan 7, 2026 |
Merson James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2026 |
Jan 7, 2026 |
Canale-Theakston Carin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2026 |
Jan 7, 2026 |
Bassler Bonnie L
|
Director |
Sell |
47.5
|
-15
|
-100.00%
|
✗
|
$3.3K |
| Jan 7, 2026 |
Jan 7, 2026 |
Mineo Chrysa
|
Director |
Sell |
40.0
|
-3,320
|
-100.00%
|
✗
|
$735.4K |
| Jan 7, 2026 |
Jan 7, 2026 |
Schroeder Theodore R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 7, 2026 |
Jan 7, 2026 |
BURGESS DANIEL D
|
Director |
Sell |
46.3
|
-150
|
-100.00%
|
✗
|
$33.2K |
| Jan 7, 2026 |
Jan 7, 2026 |
Stein Jeffrey
|
CEO |
Sell |
35.0
|
-75,640
|
-100.00%
|
✗
|
$16.8M |
| Jan 7, 2026 |
Jan 7, 2026 |
KARBE FRANK
|
CFO |
Sell |
37.5
|
-50,651
|
-100.00%
|
✗
|
$1.7M |
| Jan 7, 2026 |
Jan 7, 2026 |
Ward Shane
|
COO |
Sell |
36.3
|
-25,083
|
-100.00%
|
✗
|
$5.6M |
| Jan 7, 2026 |
Jan 7, 2026 |
Davarpanah Nicole Negar
|
Chief Medical Officer |
Sell |
37.5
|
-20,886
|
-100.00%
|
✗
|
$2.8M |
| May 23, 2016 |
Jan 7, 2026 |
Stein Jeffrey
|
CEO |
Neutral |
27.5
|
-1,864
|
-2.41%
|
✗
|
- |
| Dec 29, 2025 |
Dec 29, 2025 |
Davarpanah Nicole Negar
|
Chief Medical Officer |
Neutral |
27.5
|
-450
|
-2.11%
|
✗
|
- |
| Dec 10, 2025 |
Dec 29, 2025 |
Stein Jeffrey
|
CEO |
Neutral |
27.5
|
-5,425
|
-4.27%
|
✗
|
- |
| Dec 10, 2025 |
Dec 12, 2025 |
Stein Jeffrey
|
CEO |
Sell |
20.0
|
-2,285
|
-2.68%
|
✗
|
$501.8K |
| Dec 10, 2025 |
Dec 12, 2025 |
KARBE FRANK
|
CFO |
Sell |
17.5
|
-7,290
|
-12.60%
|
✗
|
$1.6M |
| Dec 10, 2025 |
Dec 12, 2025 |
Ward Shane
|
COO |
Sell |
16.3
|
-25,000
|
-33.48%
|
✗
|
$5.5M |
| Dec 10, 2025 |
Dec 12, 2025 |
Davarpanah Nicole Negar
|
Chief Medical Officer |
Sell |
17.5
|
-10,332
|
-32.68%
|
✗
|
$2.3M |
| Sep 11, 2025 |
Sep 15, 2025 |
Davarpanah Nicole Negar
|
Chief Medical Officer |
Sell |
46.3
|
-474
|
-1.49%
|
✗
|
$29.8K |
| Jun 26, 2025 |
Jun 30, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+2,272,727
|
207.97%
|
✗
|
$100M |
| Jun 18, 2025 |
Jun 18, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Spencer Ryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Schroeder Theodore R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Mineo Chrysa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Merson James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Canale-Theakston Carin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
BURGESS DANIEL D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Bassler Bonnie L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
Mineo Chrysa
|
Director |
Buy |
95.0
|
+3,320
|
100.00%
|
✗
|
$73.9K |
| May 1, 2025 |
May 12, 2025 |
Davarpanah Nicole Negar
|
Chief Medical Officer |
Neutral |
90.0
|
+10,000
|
46.10%
|
✗
|
- |
|
May 12, 2025 |
Davarpanah Nicole Negar
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Stein Jeffrey
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Ward Shane
|
COO |
Neutral |
90.0
|
+25,000
|
170.37%
|
✗
|
- |
| Mar 11, 2025 |
Mar 13, 2025 |
Ward Shane
|
COO |
Sell |
46.3
|
-1,664
|
-10.18%
|
✗
|
$36.5K |
| Mar 11, 2025 |
Mar 13, 2025 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Sell |
46.3
|
-1,773
|
-9.82%
|
✗
|
$38.9K |
| Feb 24, 2025 |
Feb 26, 2025 |
KARBE FRANK
|
CFO |
Neutral |
90.0
|
+57,500
|
100.00%
|
✗
|
- |
|
Feb 26, 2025 |
KARBE FRANK
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 7, 2025 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 17, 2024 |
Dec 19, 2024 |
BURGESS DANIEL D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 17, 2024 |
Dec 19, 2024 |
Schroeder Theodore R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 17, 2024 |
Dec 19, 2024 |
Mineo Chrysa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 17, 2024 |
Dec 19, 2024 |
Bassler Bonnie L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 17, 2024 |
Dec 19, 2024 |
Canale-Theakston Carin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 26, 2024 |
Nov 29, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
90.0
|
+389,716
|
55.43%
|
✗
|
- |
| Sep 30, 2024 |
Oct 2, 2024 |
Sandison Taylor
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 30, 2024 |
Oct 2, 2024 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 30, 2024 |
Oct 2, 2024 |
Stein Jeffrey
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 30, 2024 |
Oct 2, 2024 |
Shah Preetam
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 30, 2024 |
Oct 2, 2024 |
Ward Shane
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 11, 2024 |
Sep 13, 2024 |
Sandison Taylor
|
Chief Medical Officer |
Sell |
46.3
|
-924
|
-3.85%
|
✗
|
$10.8K |
| Sep 11, 2024 |
Sep 13, 2024 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Sell |
46.3
|
-909
|
-4.84%
|
✗
|
$10.6K |
| Jul 19, 2024 |
Jul 22, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 22, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
BURGESS DANIEL D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Bassler Bonnie L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Canale-Theakston Carin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Merson James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Mineo Chrysa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Schroeder Theodore R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Spencer Ryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 18, 2024 |
Jul 19, 2024 |
Tadvalkar Laura
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2024 |
Jun 11, 2024 |
Stein Jeffrey
|
CEO |
Buy |
95.0
|
+8,000
|
10.45%
|
✗
|
$105.7K |
| Apr 26, 2024 |
Apr 30, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 30, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 26, 2024 |
Apr 30, 2024 |
Spencer Ryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 30, 2024 |
Spencer Ryan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 26, 2024 |
Apr 30, 2024 |
Merson James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 30, 2024 |
Merson James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 26, 2024 |
Apr 30, 2024 |
Tadvalkar Laura
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 30, 2024 |
Tadvalkar Laura
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 20, 2024 |
Ward Shane
|
COO |
Neutral |
90.0
|
+120,000
|
60.37%
|
✗
|
- |
| Mar 15, 2024 |
Mar 20, 2024 |
Shah Preetam
|
CFO |
Neutral |
90.0
|
+108,750
|
47.86%
|
✗
|
- |
| Mar 15, 2024 |
Mar 20, 2024 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
90.0
|
+111,250
|
42.76%
|
✗
|
- |
| Mar 15, 2024 |
Mar 20, 2024 |
Sandison Taylor
|
Chief Medical Officer |
Neutral |
90.0
|
+128,750
|
37.09%
|
✗
|
- |
| Mar 15, 2024 |
Mar 20, 2024 |
Stein Jeffrey
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2024 |
Mar 12, 2024 |
Stein Jeffrey
|
CEO |
Sell |
26.3
|
-56,692
|
-3.58%
|
✗
|
$39.1K |
| Mar 11, 2024 |
Mar 12, 2024 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Sell |
46.3
|
-21,029
|
-7.48%
|
✗
|
$14.1K |
| Mar 11, 2024 |
Mar 12, 2024 |
Sandison Taylor
|
Chief Medical Officer |
Sell |
46.3
|
-20,662
|
-5.62%
|
✗
|
$13.8K |
| Mar 11, 2024 |
Mar 12, 2024 |
Ward Shane
|
COO |
Sell |
46.3
|
-20,473
|
-9.34%
|
✗
|
$13.7K |
| Mar 11, 2024 |
Mar 12, 2024 |
Shah Preetam
|
CFO |
Sell |
46.3
|
-18,931
|
-7.69%
|
✗
|
$12.7K |
| Sep 11, 2023 |
Sep 13, 2023 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Sell |
46.3
|
-18,469
|
-6.25%
|
✗
|
$17.5K |
| Sep 11, 2023 |
Sep 13, 2023 |
Sandison Taylor
|
Chief Medical Officer |
Sell |
46.3
|
-18,793
|
-4.91%
|
✗
|
$17.8K |
| Aug 14, 2023 |
Aug 14, 2023 |
Tari Leslie
|
CHIEF SCIENTIFIC OFFICER |
Buy |
82.5
|
+10,000
|
3.50%
|
✗
|
$9.7K |
| Aug 8, 2023 |
Aug 8, 2023 |
Stein Jeffrey
|
CEO |
Buy |
83.8
|
+50,000
|
3.27%
|
✗
|
$47.9K |
| Jun 22, 2023 |
Jun 23, 2023 |
Mineo Chrysa
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 23, 2023 |
Canale-Theakston Carin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 23, 2023 |
Schroeder Theodore R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 23, 2023 |
Franson Timothy R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 23, 2023 |
BURGESS DANIEL D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 23, 2023 |
Bassler Bonnie L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 22, 2023 |
Jun 23, 2023 |
Gollaher David L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2023 |
Mar 29, 2023 |
Ward Shane
|
COO |
Neutral |
90.0
|
+126,667
|
149.77%
|
✗
|
- |
| Mar 27, 2023 |
Mar 29, 2023 |
Stein Jeffrey
|
CEO |
Neutral |
90.0
|
+271,750
|
21.67%
|
✗
|
- |
| Mar 27, 2023 |
Mar 29, 2023 |
Sandison Taylor
|
Chief Medical Officer |
Neutral |
90.0
|
+90,000
|
31.19%
|
✗
|
- |